1 min read
Add as a preferred source on GoogleHaemonetics Shares Rise 14% on CSL U.S. Supply Deal Update
CSL Limited expects to deploy Haemonetics devices throughout its U.S. plasma-collection centers under the agreement.
Haemonetics shares rose about 14% in premarket trading Thursday after an update on its supply agreement with CSL Limited, which expects to deploy Haemonetics devices throughout its U.S. plasma-collection centers.
The agreement covers CSL’s U.S. plasma-collection operations.
Haemonetics’ shares were higher before the U.S. market opened on Oct. 8.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.